The Human Drugs Program at the US Food and Drug Administration was largely left out of the proposed increases in the fiscal year 2021 budget in what appears to be an adjustment of agency-wide priorities.
The budget request put more focus on other areas, only offering an increase for compounding and vaccine activities within the...